STONEPINE CAPITAL, L.P.
CIK 1370042 · last filed 2021-08-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
APEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 100-11
BEND, OR 97703
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery, Inc. (APEN) Delisted | 10%+ Owner | 1,580,518 | $10.00 | $15.81M | $499.8K | 8 | 2019-08-14 |
| QLTI | 10%+ Owner | 5,763,568 | $28.58 | $164.72M | $206.6K | 1 | 2016-09-15 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | 10%+ Owner | 91,988 | $0.03 | $3.0K | $2.00M | 1 | 2015-11-25 |
Recent Filings · Page 2 of 2
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-03 | Apollo Endosurgery, Inc. (APEN) Delisted | Buy (P) | +22,845 | $130.3K | EDGAR |
| 2017-12-28 | Apollo Endosurgery, Inc. (APEN) Delisted | Buy (P) | +5,287 | $26.4K | EDGAR |
| 2017-12-22 | Apollo Endosurgery, Inc. (APEN) Delisted | Buy (P) | +185,157 | $897.1K | EDGAR |
| 2016-12-01 | — | Grant (A) | — | $0 | |
| 2016-09-15 | QLTI | Buy (P) | +133,496 | $206.6K | EDGAR |
| 2015-11-25 | VIVEVE MEDICAL, INC. (TCON) Delisted | Buy (P) | +2,857,142 | $2.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.